🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
The purpose of this study is to evaluate a new questionnaire to capture the...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-29
Trial ID
NCT00984659
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
The purpose of this study is to compare the early onset of effect of Symbic...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00646620
Treatments Being Tested
This study compared the 14-day bronchodilator efficacy of indacaterol with ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2010-03
Trial ID
NCT01089127
Treatments Being Tested
GSK961081 has previously been administered to healthy subjects in a nebulis...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06
Trial ID
NCT00478738
Treatments Being Tested
This is a 16 week multicentre, multinational, randomised, double-blind, dou...
Status
Completed
Location
205.342.43002 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00350207
Treatments Being Tested